Physician profile
Cassi Richelle Crouch
NPI 1578043956
$1,024.17
in general payments reported to CMS, 2019-2025
14 companies · $372 in 2025
The $372 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $122 · 2022: $123 · 2023: $225 · 2024: $182 · 2025: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $779.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $779.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $266.43 | 2024-2025 | Veozah |
| Mayne Pharma Commercial LLC | $140.41 | 2021-2025 | |
| Organon LLC | $103.30 | 2021-2024 | Nexplanon |
| Exeltis, USA INC. | $90.96 | 2021-2025 | Slynd |
| Shield Therapeutics INC | $86.52 | 2023-2025 | Accrufer |
| Biogen, INC. | $82.98 | 2025 | Zurzuvae |
| Abbvie INC. | $65.85 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $37.94 | 2023 | Myfembree |
| Hologic Sales and Service, LLC | $32.35 | 2021-2025 | Novasure |
| Alexion Pharmaceuticals, INC. | $31.05 | 2023 | Ultomiris |
| Bayer Healthcare Pharmaceuticals INC. | $28.46 | 2021-2022 | |
| Amgen INC. | $25.86 | 2024 | Evenity, Prolia |
| Merck Sharp & Dohme LLC | $19.32 | 2021 | |
| Evofem Biosciences, INC. | $12.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassi Crouch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.